defense sbir sttr innovation portal dsip SBIR/STTR Programs Reauthorized: What You Need to Know DOE Prioritizes Commercialization of Cutting-Edge

That Anti-LOX (30.50 0.65 mm), HCG (28.83 0.69 mm), VED (30.75 0.25 mm), Anti-LOX + VED (33.42 0.89 mm), HCG + VED (31.17 1.55 mm), and Anti-LOX + HCG + VED (33.25 0.80 mm) significantly increased exposed length ( p 0.05) but significantly shorter than Anti-LOX ( p 0.05)

BPC-157 does not have Health Canada approval for human therapeutic use

improved wound contraction Combination studies: Limited to observational reports suggesting faster healing than either peptide alone Critical Research Limitation: Despite extensive preclinical research on individual peptides, there are NO published peer-reviewed studies examining the BPC-157 + TB-500 combination in controlled experiments

Refrigerate your bacteriostatic water after its first use

Use a short needle, typically 4mm to 8mm length